Company
Description
Founded in 2023, Illumos pioneers deep labelling reagents for light-sheet microscopy in research. Our goal is to revolutionise clinical diagnostics, making a significant impact on next-generation health care.
At Illumos Limited, where doctors, strategists, scientists, and researchers collaborate to transform healthcare delivery with groundbreaking solutions for medical research and improved patient care.